Embecta (EMBC) Non-Current Assets (2021 - 2026)
Embecta (EMBC) reported Non-Current Assets of $421.2 million for Q1 2026, down 11.66% on a YoY basis from $476.8 million in Q1 2025, and down 5.03% sequentially from $443.5 million in Q4 2025.
Embecta (EMBC) Non-Current Assets (2021 - 2026) Analysis & Trends
Embecta (EMBC) has 6 years of Non-Current Assets data on file, last reported at $421.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 11.66% year-over-year to $421.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (down 8.62% YoY), and the FY2025 full-year result was $459.5 million, down 12.36% from the prior year.
- Non-Current Assets slipped to $421.2 million in Q1 2026, from $443.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $524.3 million in Q3 2024 to a low of $407.0 million in Q1 2022.
- A 5-year average of $463.2 million and a median of $465.3 million in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets retreated 15.01% in 2022 and rose 14.5% in 2023, its largest moves.
- Tracing EMBC's Non-Current Assets over 5 years: stood at $435.2 million in 2022, then grew by 14.5% to $498.3 million in 2023, then slipped by 3.21% to $482.3 million in 2024, then declined by 8.04% to $443.5 million in 2025, then slipped by 5.03% to $421.2 million in 2026.
- Business Quant data shows EMBC's Non-Current Assets at $421.2 million in Q1 2026, $443.5 million in Q4 2025, and $459.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | 421.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 421.20 Mn |
| Dec 31, 2025 | 443.50 Mn |
| Sep 30, 2025 | 459.50 Mn |
| Jun 30, 2025 | 475.80 Mn |
| Mar 31, 2025 | 476.80 Mn |
| Dec 31, 2024 | 482.30 Mn |
| Sep 30, 2024 | 524.30 Mn |
| Jun 30, 2024 | 486.40 Mn |
| Mar 31, 2024 | 489.60 Mn |
| Dec 31, 2023 | 498.30 Mn |
| Sep 30, 2023 | 465.30 Mn |
| Jun 30, 2023 | 464.60 Mn |
| Mar 31, 2023 | 453.70 Mn |
| Dec 31, 2022 | 435.20 Mn |
| Sep 30, 2022 | 421.70 Mn |
| Jun 30, 2022 | 469.20 Mn |
| Mar 31, 2022 | 407.00 Mn |
| Dec 31, 2021 | 481.60 Mn |
| Sep 30, 2021 | 496.20 Mn |